Medical/Pharmaceuticals APAC News & Press Release Distribution

Innovent Will Present Clinical Data of IBI110 (anti-LAG-3 monoclonal antibody) and Other Multiple Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, May 16, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-05-16 08:00 3130

Seegene reports first quarter 2022 financial results

* Q1 revenue up 10% QoQ to reach record quarterly high of KRW 451.5 billion * Foundation for sales expansion strengthened through '3 Ct' technology commercialization, Allplex™ RV Master Assay approval, increased PCR instrument sales * "Seegene to secure future growth by targeting syndromic t...

2022-05-13 19:00 2599

Antengene Announces XPOVIO® (selinexor) Data to be Presented at the Upcoming 2022 European Hematology Association Hybrid Congress

SHANGHAI and HONG KONG, May 13, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-05-13 18:00 2560

NEW GUIDELINES FOR COVID TESTING

A new ISO technical specification will improve testing procedures and contribute to a safer world. SHENZHEN, China, May 13, 2022 /PRNewswire/ -- The COVID pandemic first reared its head in 2019 and despite concerted efforts from authorities and the public, it's still with us. Dedicated stan...

2022-05-13 17:10 2026

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

SHANGHAI and HONG KONG, May 13, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-05-13 08:30 2341

ECCMID 2022: Copan unveils its WISE approach to sample management

BRESCIA, Italy, May 12, 2022 /PRNewswire/ -- Copan took the chance of the first in-person ECCMID of the last two years to give a name to itsholistic approach to preanalytics. From sample collection to image analysis and data interpretation, meet Copan's WISE approach, which brings any sample to i...

2022-05-12 20:25 2038

ECCMID 2022: Copan unveils its WISE approach to sample management

INFOBAE.COM: Houston doctors and researchers that are making the biggest international impact according to the KOLs list - Most of them are women

SANTA BARBARA, Calif., May 12, 2022 /PRNewswire/ -- The work of Houston doctors and researchers is getting international attention. The most researched areas in Houston after COVID are Oncology, Cardiology, and Endocrinology. According to the KOLs list, the leading institutions are The University ...

2022-05-12 08:22 1442

DetectedX Launches Radiology Online Learning Platform to the U.S. Market at SBI

The Intelligent Interactive Educational Technology from DetectedX has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SAVANNAH, Ga., May 11, 2022 /PRNewswire/ -- DetectedX announced today that it will launch its Radiology Online Learning Platform...

2022-05-11 20:00 2338

WORLD BRAIN DAY 2022 IS DEDICATED TO BRAIN HEALTH FOR ALL

LONDON, May 11, 2022 /PRNewswire/ -- On Friday, July 22, the World Federation of Neurology (WFN) is hosting the 9th Annual World Brain Day. WFN is pleased to announce that this year's theme isBrain Health for All. The all-encompassing theme aims to spark a universal effort that will share crucial...

2022-05-11 14:00 1780

WORLD BRAIN DAY 2022 IS DEDICATED TO BRAIN HEALTH FOR ALL

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

GAITHERSBURG, Md. and SUZHOU, China, May 11, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments o...

2022-05-11 13:05 2137

Prenetics and Artisan Acquisition Corp. Announce Shareholder Approval of Business Combination, To Begin Trading on Nasdaq on May 18 Under the Ticker "PRE"

* At Least US$260M of Proceeds from the Business Combination, Cash and Trade Receivables to Support Prenetics Growth * Closing of the Business Combination is Expected to Occur on May 18, 2022[1] * Prenetics Shares to Begin Trading on Nasdaq on May 18, 2022[1] Under Ticker "PRE" HONG KONG, Ma...

2022-05-11 09:00 2271

Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients

HANGZHOU, China and SHAOXING, China, May 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the Investigational New Drug (IND) application approval of ASC22 (Envafolimab) by U.S. Food and Drug Administration (FDA) for the indication of immune restoration/functi...

2022-05-11 08:40 2045

RhoVac AB announces Database Lock in its clinical phase IIb trial of onilcamotide

STOCKHOLM, Sweden, May 11, 2022 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company,announced on May 10th, 2022, that its phase IIb study in prostate cancer, BRaVac, has reached "Database Lock". This means that all data from the trial is now finally reported, cleaned and...

2022-05-11 06:42 1724

Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition

HONG KONG, May 11, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company has received a copy ...

2022-05-11 04:16 2159

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market TAIPEI, May 10, 2022 /PRNewswire/ -- Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the esta...

2022-05-10 17:53 2744

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

OMRON Healthcare Unveils Long-term Corporate Vision, "Going for ZERO, Preventive Care for Health of Society"

- Aiming to Realize 3 Zeros: "Zero Cerebrovascular and Cardiovascular Events," "Zero Aggravation of Respiratory Diseases" and "Zero Restrictions on Daily Activities Due to Chronic Pain" - KYOTO, Japan, May 10, 2022 /PRNewswire/ -- In March 2022, OMRON Group announced a new long-term vision, "Sha...

2022-05-10 13:00 1938

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse

* The Consortium jointly, through Aztiq II HoldCo, has completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo * Róbert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma ...

2022-05-10 11:00 2348

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse

Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant

* Studies conducted by independent labs demonstrate the amubarvimab/romlusevimab combination retains neutralizing activity against COVID-19 Omicron variant * Review of the monoclonal antibody combination therapy is underway by the U.S. Food and Drug Administration (FDA) for Emergency Use Auth...

2022-05-09 19:46 2153

Series A financing round lays foundation for international growth of digital cancer therapeutics Mika

New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering people affected by cancer. BERLIN, LAUSANNE,Switzerland, BARCELONA,Spain and MUNICH, May 9, 2022 /PR...

2022-05-09 19:35 1899

SCG Cell Therapy announces clinical trial approval of TCR-T cell therapy for liver cancer in Singapore

*SCG101 - autologous T-cell receptor (TCR) T-cell therapy for liver cancer *SCG101 is the first TCR-T cell therapy product to receive a multi-country clinical trial approval from Singapore and China the treatment of HCC *APAC accounts for four in five new cases of liver across globally Singapor...

2022-05-09 10:28 3423